{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:09:24Z","timestamp":1788815364791,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijgc.2026.104818","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:14:44Z","timestamp":1781936084000},"page":"104818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2548-8017","authenticated-orcid":false,"given":"Matilda","family":"Salko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7462-3003","authenticated-orcid":false,"given":"Lasse","family":"Myllylahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Palomino-Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Tapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Koivisto-Korander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Nelskyl\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4372-2367","authenticated-orcid":false,"given":"Mikko","family":"Loukovaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniina","family":"F\u00e4rkkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1629-6400","authenticated-orcid":false,"given":"Ulla-Maija","family":"Haltia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2026.104818_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/14791641241236894","article-title":"A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities","volume":"21","author":"Myllylahti","year":"2024","journal-title":"Diab Vasc Dis Res"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104818_bib2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/bjc.2014.3","article-title":"Thrombosis in ovarian cancer: a case control study","volume":"110","author":"Metcalf","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijgc.2026.104818_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2016.12.002","article-title":"Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression","volume":"150","author":"Swier","year":"2017","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104818_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104818_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ajog.2023.10.006","article-title":"Risk of thrombosis and bleeding in gynecologic cancer surgery: systematic review and meta-analysis","volume":"230","author":"Lavikainen","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104818_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2010.11.038","article-title":"Incidence and timing of venous thromboembolism after surgery for gynecological cancer","volume":"121","author":"Peedicayil","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104818_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/IGC.0000000000000415","article-title":"High pretreatment plasma D-dimer levels are associated with poor prognosis in patients with ovarian cancer independently of venous thromboembolism and tumor extension","volume":"25","author":"Sakurai","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104818_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/1076029618779133","article-title":"Preoperative biomarker panel, including fibrinogen and FVIII, improves diagnostic accuracy for pancreatic ductal adenocarcinoma","volume":"24","author":"Mattila","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104818_bib9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/jth.13071","article-title":"Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study","volume":"13","author":"Yap","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104818_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","article-title":"Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer","volume":"5","author":"Konstantinopoulos","year":"2015","journal-title":"Cancer Discov."},{"issue":"7353","key":"10.1016\/j.ijgc.2026.104818_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104818_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ijgc-2021-002951","article-title":"European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery","volume":"31","author":"Fotopoulou","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104818_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104818_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/bjc.2016.27","article-title":"Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas","volume":"114","author":"Hiramatsu","year":"2016","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104818_bib15","first-page":"87","article-title":"Factor VIIIR:ag plasma levels in patients with cervical and ovarian carcinoma","volume":"9","author":"Facchini","year":"1988","journal-title":"Eur J Gynaecol Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104818_bib16","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104818_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2021.07.030","article-title":"Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy","volume":"163","author":"Basaran","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104818_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2023.06.577","article-title":"Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: is it time for thromboprophylaxis?","volume":"176","author":"Shafa","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104818_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41698-023-00402-y","article-title":"HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients","volume":"7","author":"Li","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104818_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104818_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"9990","key":"10.1016\/j.ijgc.2026.104818_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104818_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ijgc-2019-000682","article-title":"TRUST: trial of radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"29","author":"Reuss","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"suppl 17","key":"10.1016\/j.ijgc.2026.104818_bib24","article-title":"TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"43","author":"Mahner","year":"2025","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104818_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/SLA.0b013e31824daccb","article-title":"Postoperative venous thromboembolism predicts survival in cancer patients","volume":"255","author":"Auer","year":"2012","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104818_bib26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s12032-011-0019-5","article-title":"Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer","volume":"29","author":"Asher","year":"2012","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104818_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/rth2.12143","article-title":"Cancer-associated thrombosis: the search for the Holy Grail continues","volume":"2","author":"\u00dcnl\u00fc","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.ijgc.2026.104818_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109240","article-title":"Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma","volume":"246","author":"Bosch","year":"2025","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104818_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107710","article-title":"Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives","volume":"300","author":"Zhao","year":"2024","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104818_bib30","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/ijms23052702","article-title":"NADPH oxidase 4 (NOX4) in cancer: linking redox signals to oncogenic metabolic adaptation","volume":"23","author":"Szanto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijgc.2026.104818_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216207","article-title":"LIMK2: a multifaceted kinase with pleiotropic roles in human physiology and pathologies","volume":"565","author":"Shah","year":"2023","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104818_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12957-021-02377-1","article-title":"Over-expression of SRD5A3 and its prognostic significance in breast cancer","volume":"19","author":"Zhang","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ijgc.2026.104818_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7853168","article-title":"Overexpression of SRD5A3 in hepatocellular carcinoma and its molecular mechanism: a study of bioinformatics exploration analysis with experimental verification","volume":"2022","author":"Chen","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"21","key":"10.1016\/j.ijgc.2026.104818_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111423","article-title":"NRXN1 as a prognostic biomarker: linking copy number variation to EMT and survival in Colon cancer","volume":"25","author":"Bang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104818_bib35","article-title":"Mechanisms of GPM6A in malignant tumors. Cancer rep","volume":"8","author":"Huang","year":"2025","journal-title":"Cancer Rep (Hoboken)"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104818_bib36","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/cancers14061496","article-title":"Molecular correlates of venous thromboembolism (VTE) in ovarian cancer","volume":"14","author":"Glassman","year":"2022","journal-title":"Cancers"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2600349X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2600349X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:47:50Z","timestamp":1788814070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2600349X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1048891X2600349X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104818","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-operative venous thromboembolism in advanced epithelial ovarian cancer: risk factors, tumor gene expression, and survival","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104818"}}